1 suspended, 1 terminated, 1 unknown. 1 Early Phase 1, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Terminated 1 |
| Phase 1 | 1 | Suspended 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Avemar: new trials by email Literature Review of Avemar trials Research Report on Avemar
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Immune Effects of Fermented Wheat Germ Nutritional Supplementation in Patients With Advanced Solid Tumor Cancers Being Treated With Standard of Care Checkpoint Inhibitors Fermented Wheat Germ Extract - Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma | Phase 1 | Suspended | University of California, Davis | 100 | 2023-06-02 | 2026-07-01 |
| Fermented Wheat Germ Extract in Women With Ovarian Cancer Fermented Wheat Germ Extract (FWGE), Placebo, Standard of Care: Planned Surgery - Ovarian Cancer | Early Phase 1 | Terminated | H. Lee Moffitt Cancer Center and Research Institute | 3 | 2016-03-01 | 2019-01-23 |
| Efficacy of FWGE in Combination With Hormone Therapy for the Treatment of Hormone-Refractory Prostate Cancer Patients Fermented Wheat germ extract - Hormone Refractory Prostate Cancer | Phase 2 | Unknown | Sheba Medical Center | 60 | 2007-06-01 | 2009-07-31 |
Carcinoma, Renal Cell (1) · Colorectal Neoplasms (1) · Lung Neoplasms (1) · Neoplasms (1) · Ovarian Neoplasms (1)
H. Lee Moffitt Cancer Center and Research Institute (1) · Sheba Medical Center (1) · University of California, Davis (1)
United States (2) · Israel (1)
Hye Sook Chon, M.D. (1) · Joseph M Tuscano, MD (1) · Rony Weitzen, MD (1)
P30CA093373 (1)